[CLSTR]
< Back to situation

[REVISION HISTORY]

Expansion of BCI clinical and industrial applications

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-09-03 21:26 UTC → 2026-09-14 00:55 UTC · added removed

Advancements in neuro-rehabilitation and Expansion of BCI technology clinical and industrial applications

China has approved the first commercial brain implant, known as NEO, for individuals with tetraplegia. Developed by Neuracle Technology and Tsinghua University, is expanding the Brain-Computer Interface use of brain-computer interfaces (BCI) uses artificial intelligence to convert electrical activity from the motor cortex into commands for computers or robotic devices. The technology aims laboratory settings to facilitate “bridging neural repair” clinical and industrial applications, particularly in Shanghai. This transition is supported by synchronizing brain signals with sensory input to encourage nervous system reorganization. As the BCI industry expands globally, China has designated government’s 15th Five-Year Plan (2026–2030), which designates the sector as strategic in its five-year plan. Beyond a priority. In Shanghai’s Minhang district, the NEO implant, Tianjin-based Tiankai Suishi Intelligent Technology Brain Intelligence Valley has received market approval for emerged as a multi-electrode headset used national hub hosting over 50 companies. Building on previous approvals, Neuracle Technology (Shanghai) Co., Ltd. has developed an invasive BCI medical device designed to assess compensate for hand motor functions using electrodes implanted between the skull and diagnose cognitive functions. The rise of these technologies has prompted the dura mater. To support widespread adoption, health insurance companies to begin announcing commercial policies authorities are currently working on product coding to cover necessary invasive implantation surgeries. These facilitate patient coverage. Further clinical advancements are driving significant growth in broader neuro-rehabilitation markets. The rehabilitation robotics market is expected to grow from USD 1.81 billion in 2025 to USD 4.87 billion by 2030, fueled being led by rising incidences of stroke and traumatic brain injury. Similarly, the cerebral palsy treatment market MingShi Brain Computer Technology, which is projected conducting studies on vision reconstruction for blind patients. By using surgically implanted electrodes to reach USD 4.39 billion by 2031, supported by improved neonatal screening protocols like General Movement Assessment and advancements in telehealth and AI-driven personalized therapy. However, stimulate the proliferation of experimental neural devices introduces ethical and logistical challenges. As clinical trials conclude, concerns have emerged regarding visual cortex, the long-term support system has demonstrated the ability to provide partial visual recovery. This research targets a significant global need, addressing the needs of participants approximately 9 million blind individuals in China and whether patients can continue using devices “off-label” if sponsors lack funding for lifelong maintenance. over 43 million worldwide.

Versions

  1. 2026-09-14 00:55 UTC Expansion of BCI clinical and industrial applications
  2. 2026-09-03 21:26 UTC Advancements in neuro-rehabilitation and BCI technology
  3. 2026-08-21 01:39 UTC Advancements in neuro-rehabilitation technology

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.